Viemed (VMD) Director Sabrina Heltz Receives Awards, Cash-Settles Phantom Shares

What Happened

• Sabrina Heltz, a director of Viemed Healthcare (VMD), had equity awards vest and be settled in mid‑August 2026. On Aug 19, 2026 she cashed out 3,757 phantom share units at $8.94 per unit for proceeds of $33,588. The filing also records conversion/exercise entries for 15,029 and 3,757 derivative units related to vested awards (one set treated as RSUs and one as phantom share units). Separately, on Aug 17, 2026 she was granted 12,174 Restricted Stock Units (RSUs) and 3,043 phantom share units that vest on the first anniversary of the grant.

Key Details

• Transaction dates: grants on Aug 17, 2026; vesting/settlement reported Aug 19, 2026 (period of report lists Aug 17, 2026 for the grants).
• Cash proceeds: 3,757 phantom shares cashed out at $8.94 = $33,588 (per‑share value based on 8/19/2026 close).
• Other entries: 15,029 units appear as RSU conversions/exercises (no cash reported) and 3,757 derivative units reported as disposed/settled (cash‑settled phantom shares).
• Shares owned after transaction: not specified in the provided filing.
• Notable footnotes: RSUs = right to one common share (F1); phantom shares = cash‑settled units equal to one share’s economic value (F2, F7); the vested Aug 19, 2026 items stem from awards granted Aug 19, 2025 (F4, F5); the Aug 17, 2026 awards vest in one year (F6, F8).
• Filing timeliness: filing dated Aug 19, 2026; no late‑filing indicator was reported in the provided data.

Context

• These were compensation‑related transactions: RSUs and phantom share units vesting and being settled. The phantom units were cash‑settled (you received cash rather than holding shares), and the RSU conversions were reported as derivative exercises/settlements (no purchase outlay reported). Such vesting/settlements are routine for insiders and do not by themselves indicate a personal buy or sell decision unrelated to compensation.